SBIO

ALPS Medical Breakthroughs ETF
CLOSING PRICECHANGE (%)VOLUME
$26.68+0.04 (0.15%)43.57K
4:00:00 p.m. (ET) 04/27/2017
BZX EXCHANGE CLOSED
LAST TRADECHANGE (%)
---- (--)
BID SIZEBID ($)ASK ($)ASK SIZE
--------

Overall Rating

N/A

N/A
as of 04/27/17

Rating Details

N/A
N/A
N/A
Segment Average
  • Overview
  • Efficiency
  • Tradability
  • Fit

SBIO Fund Description

The ALPS Medical Breakthroughs ETF tracks the Poliwogg Medical Breakthroughs Index, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

SBIO FactSet Analytics Insight

The ALPS Medical Breakthroughs ETF (SBIO)high-risk and high-reward targets biotech companies with drugs in Phase II and Phase III of FDA clinical trials. The fund limits itself to US-listed companies with market caps between $200M and $5B. SBIO also has screens for liquidity and sustainability of its constituents. (Sustainability in this context means that constituent firms have enough cash on hand to last 2 years.) Given the low historical success rates in clinical trials, the fund is a high-risk and high-reward bet on a small subset of biotech companies. If you’re looking for broad biotech exposure, you won’t find it in SBIO; however, you will find a new competing fund with a similar thesis in BBC. Check back in 6 months for more detailed analysis.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

SBIO Top 10 Countries

SBIO Top 10 Sectors

SBIO Top 10 Holdings

This chart is unavailable

SBIO Summary Data

12/31/14
Open-Ended Fund
0.50%
$105.67 M
$969.44 K
0.40%

SBIO Portfolio Data

$2.59 B
-10.60
4.15
0%
12/20/17
83

SBIO Index Data

Poliwogg Medical Breakthroughs Index
Market Cap
Fundamental
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to SBIO

N/A
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

SBIO Portfolio Management

0.50%
--
--
--

SBIO Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

SBIO Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:17:1426.70100
14:37:4026.77100
12:35:4326.68100
------
------
------
------
------
------
------
Bats BZX Real-time Quote - 17:56:24
Average Spread
Premium/Discount
Volume

SBIO FactSet Analytics Block Liquidity

As of 04/27/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of SBIO. SBIO is rated a 5 out of 5.

SBIO Tradability

37,226
$969.44 K
24,207
$622.88 K
0.40%
$0.1
-0.05%
0.22% / -0.25%
None
100.00%
50,000
0.48
0.04%
0.21%
722
$26.64
5

SBIO Performance Statistics

0.79
1.37
1.36
1.34
1.10%
Thomson Reuters US Biotechnology & Medical Research